Establishment of a Feasibility Model for NOSE Surgery Based on Machine Learning
Launched by SIXTH AFFILIATED HOSPITAL, SUN YAT-SEN UNIVERSITY · Apr 3, 2023
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to perform surgery for patients with certain types of rectosigmoid cancers, which are cancers located in the lower part of the colon and rectum. The researchers want to see if they can use advanced computer technology, called machine learning, to help predict how well a specific surgical method called Natural Orifice Specimen Extraction Surgery (NOSES) will work. This method aims to remove tumors through natural openings in the body, which can lead to quicker recovery and less pain compared to traditional surgery.
To participate in this trial, patients should be between the ages of 65 and 74 and have been diagnosed with colorectal cancer that is not too advanced (specifically, their tumors should be at stage T3 or lower). They will also need clear imaging results, like CT or MRI scans, so the doctors can assess their condition properly. Those who have had previous treatments or have more severe cancer stages may not be eligible. If chosen to join, participants can expect thorough evaluations before and during the surgery to ensure the best possible outcome. This study is not yet recruiting participants, but it aims to help improve surgical options for patients with colorectal cancer in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients diagnosed with colorectal cancer or large adenoma who are suitable for laparoscopic colorectal surgery;
- • 2. Tumor staging ≤ T3 without invasion of surrounding organs;
- • 3. No abdominal seeding or distant organ metastasis;
- • 4. Clear and complete imaging data (CT, pelvic MRI) that can be processed by a computer;
- • 5. Feasible evaluation and determination for obtaining specimens through the rectal channel during preoperative and intraoperative assessments.
- Exclusion Criteria:
- • 1. Contraindications for laparoscopic colorectal surgery;
- • 2. Tumor staging is T4, or there are cancer nodules;
- • 3. Presence of metastasis or distant organ metastasis;
- • 4. Incomplete imaging data;
- • 5. Preoperative intestinal obstruction;
- • 6. Tumor or specimen diameter larger than the transverse diameter of the pelvic outlet;
- • 7. Previous rectal radiotherapy;
- • 8. Unsuitable evaluation and determination for obtaining specimens through the rectal channel during preoperative and intraoperative assessments.
About Sixth Affiliated Hospital, Sun Yat Sen University
The Sixth Affiliated Hospital of Sun Yat-sen University is a leading medical institution in China, dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent academic hospital, it integrates clinical practice with research excellence, fostering collaboration among multidisciplinary teams to enhance medical knowledge and improve patient outcomes. The hospital is committed to conducting rigorous clinical trials that adhere to the highest ethical standards, aiming to contribute to the global scientific community and support the development of new therapies and interventions. With a focus on translational medicine, the Sixth Affiliated Hospital actively engages in pioneering studies that address critical health challenges and promote evidence-based practices in diverse medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials